These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 31427906)

  • 1. Prognostic Value of Functional Parameters of
    Wang M; Xu H; Xiao L; Song W; Zhu S; Ma X
    Contrast Media Mol Imaging; 2019; 2019():2641627. PubMed ID: 31427906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Overall Survival and Progression-Free Survival by the
    Zhou Y; Ma XL; Pu LT; Zhou RF; Ou XJ; Tian R
    Contrast Media Mol Imaging; 2019; 2019():5963607. PubMed ID: 31777473
    [No Abstract]   [Full Text] [Related]  

  • 3. Association of
    Önner H; Coskun N; Erol M; Eren Karanis Mİ
    Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):11-16. PubMed ID: 34991831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.
    Ganeshan B; Miles KA; Babikir S; Shortman R; Afaq A; Ardeshna KM; Groves AM; Kayani I
    Eur Radiol; 2017 Mar; 27(3):1012-1020. PubMed ID: 27380902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ability of
    Ou X; Wang J; Zhou R; Zhu S; Pang F; Zhou Y; Tian R; Ma X
    Contrast Media Mol Imaging; 2019; 2019():4507694. PubMed ID: 30930700
    [No Abstract]   [Full Text] [Related]  

  • 6. Intratumor Heterogeneity Assessed by
    Lue KH; Wu YF; Liu SH; Hsieh TC; Chuang KS; Lin HH; Chen YH
    Acad Radiol; 2020 Aug; 27(8):e183-e192. PubMed ID: 31761665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic value of SUVmax measured by pretreatment 18F-FDG PET/CT in patients with primary gastric lymphoma.
    Hwang JP; Lim I; Byun BH; Kim BI; Choi CW; Lim SM
    Nucl Med Commun; 2016 Dec; 37(12):1267-1272. PubMed ID: 27482643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of baseline
    Albano D; Bosio G; Camoni L; Farina M; Re A; Tucci A; Giubbini R; Bertagna F
    Hematol Oncol; 2019 Feb; 37(1):39-46. PubMed ID: 30299563
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intratumoral heterogeneity in
    Molina-García D; García-Vicente AM; Pérez-Beteta J; Amo-Salas M; Martínez-González A; Tello-Galán MJ; Soriano-Castrejón Á; Pérez-García VM
    Ann Nucl Med; 2018 Jul; 32(6):379-388. PubMed ID: 29869770
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Parvez A; Tau N; Hussey D; Maganti M; Metser U
    Ann Nucl Med; 2018 Jul; 32(6):410-416. PubMed ID: 29754276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role in staging and prognostic value of pretherapeutic F-18 FDG PET/CT in patients with gastric MALT lymphoma without high-grade transformation.
    Park YJ; Hyun SH; Moon SH; Lee KH; Min BH; Lee JH; Kim WS; Kim SJ; Choi JY
    Sci Rep; 2021 Apr; 11(1):9243. PubMed ID: 33927319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic and prognostic value of 18F-FDG PET/CT in comparison with morphological imaging in primary adrenal gland malignancies - a multicenter experience.
    Cistaro A; Niccoli Asabella A; Coppolino P; Quartuccio N; Altini C; Cucinotta M; Alongi P; Balma M; Sanfilippo S; Buschiazzo A; Piccardo A; Fanelli M; Sambuceti G; Bomanji J; Baldari S; Bisi G; Fanti S; Rubini G
    Hell J Nucl Med; 2015; 18(2):97-102. PubMed ID: 26187207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early restaging positron emission tomography with ( 18)F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma.
    Spaepen K; Stroobants S; Dupont P; Vandenberghe P; Thomas J; de Groot T; Balzarini J; De Wolf-Peeters C; Mortelmans L; Verhoef G
    Ann Oncol; 2002 Sep; 13(9):1356-63. PubMed ID: 12196360
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Usefulness of Machine Learning-Based Evaluation of Clinical and Pretreatment [
    Nakajo M; Kawaji K; Nagano H; Jinguji M; Mukai A; Kawabata H; Tani A; Hirahara D; Yamashita M; Yoshiura T
    Mol Imaging Biol; 2023 Apr; 25(2):303-313. PubMed ID: 35864282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting neo-adjuvant chemotherapy response and progression-free survival of locally advanced breast cancer using textural features of intratumoral heterogeneity on F-18 FDG PET/CT and diffusion-weighted MR imaging.
    Yoon HJ; Kim Y; Chung J; Kim BS
    Breast J; 2019 May; 25(3):373-380. PubMed ID: 29602210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic value of textural features obtained from F-fluorodeoxyglucose (F-18 FDG) positron emission tomography/computed tomography (PET/CT) in patients with locally advanced cervical cancer undergoing concurrent chemoradiotherapy.
    Cho HW; Lee ES; Lee JK; Eo JS; Kim S; Hong JH
    Ann Nucl Med; 2023 Jan; 37(1):44-51. PubMed ID: 36369325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Value of Tumor Heterogeneity and SUVmax of Pretreatment 18F-FDG PET/CT for Salivary Gland Carcinoma With High-Risk Histology.
    Cheng NM; Hsieh CE; Liao CT; Ng SH; Wang HM; Fang YD; Chou WC; Lin CY; Yen TC
    Clin Nucl Med; 2019 May; 44(5):351-358. PubMed ID: 30932974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.
    Albano D; Bertoli M; Battistotti M; Rodella C; Statuto M; Giubbini R; Bertagna F
    Ann Nucl Med; 2018 Oct; 32(8):532-541. PubMed ID: 29982990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Textural features of pretreatment 18F-FDG PET/CT images: prognostic significance in patients with advanced T-stage oropharyngeal squamous cell carcinoma.
    Cheng NM; Fang YH; Chang JT; Huang CG; Tsan DL; Ng SH; Wang HM; Lin CY; Liao CT; Yen TC
    J Nucl Med; 2013 Oct; 54(10):1703-9. PubMed ID: 24042030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Importance of Bone Marrow Uptake on Baseline
    Soydal C; Koksoy EB; Yasar A; Turgal E; Erdogan BD; Akbulut H; Kucuk NO
    Cancer Biother Radiopharm; 2016 Dec; 31(10):361-365. PubMed ID: 27996313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.